-
Medical journals
- Career
Transfusion and Haematology Today - Issue 4/2017
185Next generation sequencing in acute myeloid leukaemia: new insights into the pathogenesis and development of leukemic clonesM. Čulen, Z. Kosařová, I. Ježíšková, A. Folta, D. Dvořáková, L. Semerád, Z. Šustková, Z. Ráčil
192Possible discontinuation of treatment by tyrosine kinase inhibitors in patients with chronic myeloid leukemia and concept of treatment-free remissionJ. Šrámek, M. Karas, D. Lysák, P. Jindra
199The first oral proteasome inhibitor in the treatment of relapsed/refractory multiple myelomaH. Plonková, T. Jelínek, L. Szeligová, R. Hájek
210Epigenetic changes as a novel tool for prognostic stratifying chronic lymphocytic leukaemiaL. Poppová, K. Plevová, Š. Pospíšilová
215Angioimmunoblastic T-lymphoma: overview, single centre experience and case report of the sequential development of difuse large B-cell lymphomaJ. Michalka, A. Janíková, J. Soukup, M. Kalinová, L. Křen, Z. Král, M. Mayer
223
Transfusion and Haematology Today
2017 Issue 4
Most read in this issue- Angioimmunoblastic T-lymphoma: overview, single centre experience and case report of the sequential development of difuse large B-cell lymphoma
- Next generation sequencing in acute myeloid leukaemia: new insights into the pathogenesis and development of leukemic clones
- Possible discontinuation of treatment by tyrosine kinase inhibitors in patients with chronic myeloid leukemia and concept of treatment-free remission
- The first oral proteasome inhibitor in the treatment of relapsed/refractory multiple myeloma
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career